GSK acquires Rapt Therapeutics inventory for $2.2 billion as Leerink downgrades
GSK acquires Rapt Therapeutics inventory for $2.2 billion as Leerink downgrades
Figure Heloc(FIGR_HELOC)$1.030.95%
Hyperliquid(HYPE)$59.58-5.36%Sign in to your account